Oxidative stress in atrial fibrillation: An emerging role of NADPH oxidase
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Patients with AF have up to seven-fold higher risk of suffering from ischemic stroke. Better understanding of etiologies of AF and its thromboembolic complications are required for improved patient care, as current anti-arrhythmic therapies have limited efficacy and off target effects. Accumulating evidence has implicated a potential role of oxidative stress in the pathogenesis of AF. Excessive production of reactive oxygen species (ROS) is likely involved in the structural and electrical remodeling of the heart, contributing to fibrosis and thrombosis. In particular, NADPH oxidase (NOX) has emerged as a potential enzymatic source for ROS production in AF based on growing evidence from clinical and animal studies. Indeed, NOX can be activated by known upstream triggers of AF such as angiotensin II and atrial stretch. In addition, treatments such as Statins, antioxidants, ACEI or AT1RB have been shown to prevent post-operative AF; among which ACEI/AT1RB and Statins can attenuate NOX activity. On the other hand, detailed molecular mechanisms by which specific NOX isoform(s) are involved in the pathogenesis of AF and the extent to which activation of NOX plays a causal role in AF development remains to be determined. The current review discusses causes and consequences of oxidative stress in AF with a special focus on the emerging role of NOX pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333 · cited 3×
“1 million adults in 2010 in the United States [1], among which 14–16% die of ischemic stroke [1].”
BackgroundInfluentialBenjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899 · cited 1×
“NOX isoforms [NOX1–5 or dual oxidase 1–2 (Duox)] recruit separate regulatory subunits for enzymatic assembly and activation [33].”
BackgroundCucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786 · cited 1×
“For instance, NOX4 promotes apoptosis in cardiomyocytes by generating H2O2 [45], while it also induces H2O2-dependent proliferation in fibroblasts [51], both of which contribute to pathogenesis of heart failure [52].”
BackgroundFunctional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases
Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., & Knaus, U. G. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.023 · Cited by 783 · cited 1×
“only H2O2 that diffuses out of these compartments gets detected) [49, 50].”
BackgroundNADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772 · cited 3×
“For instance, NOX4 promotes apoptosis in cardiomyocytes by generating H2O2 [45], while it also induces H2O2-dependent proliferation in fibroblasts [51], both of which contribute to pathogenesis of heart failure [52].”
BackgroundLaursen, J. B., Somers, M., Kurz, S., McCann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., & Harrison, D. G. (2001) · Circulation · doi:10.1161/01.cir.103.9.1282 · Cited by 721
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Cai, H., Griendling, K. K., & Harrison, D. G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00233-5 · Cited by 687 · cited 9×
“It has been reported that Ang II infusion leads to oxidation of Met 281/282 residues in the regulatory domain of CaMKII, which transforms CaMKII into a constitutively active form, leading to secondary electrical remodeling by inducing calcium overload via activation of L-type calcium channel and ryanodine receptor 2 (…”
BackgroundInfluentialSelf-citationNOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation
Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., Sienkiewicz, A., Fórró, L., Schlegel, W., & Krause, K.-H. (2007) · Biochemical Journal · doi:10.1042/bj20061903 · Cited by 627 · cited 1×
“only H2O2 that diffuses out of these compartments gets detected) [49, 50].”
Background
Cited by
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“Activation of NOX2 and NOX4 occurs in humans with atrial fibrillation and inhibition of NOX by angiotension converting enzyme inhibitor drugs or statins has proved helpful in preventing post-operative atrial fibrillation (54).”
BackgroundAngiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Atrial Remodeling and Atrial Fibrillation
Nattel, S., & Harada, M. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.555 · Cited by 736
NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets
Zhang, Y., Murugesan, P., Huang, K., & Cai, H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 534
Self-citationMolecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation
Nattel, S. (2017) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2017.03.002 · Cited by 491
Role of Inflammation in Atrial Fibrillation Pathophysiology and Management
Harada, M., Van Wagoner, D. R., & Nattel, S. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0138 · Cited by 473
Alcohol Consumption and Risk of Atrial Fibrillation
Larsson, S. C., Drca, N., & Wolk, A. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.048 · Cited by 436
Liu, L., Jin, X., Hu, C.-F., Li, R., Zhou, Z., & Shen, C.-X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000480317 · Cited by 321
Oudemans-van Straaten, H. M., Man, A. M. S.-D., & de Waard, M. C. (2014) · Critical Care · doi:10.1186/s13054-014-0460-x · Cited by 299
“Its pathogenesis is multimodal but accumulating evidence indicates a role of oxidative stress [92-94].”
BackgroundInflammation, oxidative stress and postoperative atrial fibrillation in cardiac surgery
Zakkar, M., Ascione, R., James, A. F., Angelini, G. D., & Suleiman, M. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.009 · Cited by 274
Martínez-González, M. Á., Toledo, E., Arós, F., Fiol, M., Corella, D., Salas-Salvadó, J., Ros, E., Covas, M. I., Fernández-Crehuet, J., Lapetra, J., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006921 · Cited by 216
“Finally, the effect could have been mediated through a decrease in CVD, which is a known risk factor for AF.20 However, an analysis that adjusted for the primary end point of the PREDIMED trial (myocardial infarction, stroke, or CVD death) provided similar results, which suggests that other mechanisms might be respons…”
BackgroundInfluentialJoca, H. C., Santos‐Miranda, A., Joviano-Santos, J. V., Maia-Joca, R. P. M., Brum, P. C., Williams, G. S. B., & Cruz, J. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-64949-7 · Cited by 24
Metadata
- Authors
- Youn, J.-Y., Zhang, J., Zhang, Y., Chen, H., Liu, D., Ping, P., Weiss, J. N., & Cai, H.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Pages
- 72-79
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2170737858
- Cited by
- 214
- References
- 22
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.